Correlations between the neuroelectrical maturation and cellular development of cerebral organoids highlight the organoids’ translational and therapeutical potential in early neurodevelopmental disorders.
Researchers take a systematic approach toward their goal of developing an efficacious implant.
Randomized, controlled clinical trials are needed to answer questions regarding when and with whom to use the device.
CMV is the leading non-genetic cause of sensorineural hearing loss in infancy and childhood. Identification of newborns with congenital CMV infection can improve their outcomes by early intervention programs and/or antiviral treatment.
Researchers from Nationwide Children’s Hospital use a collaborative approach to combat a serious health care threat.
Innovative prevention and treatment strategies bolstered by a deeper understanding of pathology may indicate a major shift on the horizon.
